AI Overview
Is IPO GMP reliable? IPO GMP is directionally useful but not precisely accurate. Historical analysis of Indian IPOs from 2020–2025 shows that GMP’s directional accuracy (whether a stock lists at a gain or loss) is roughly 70–75%. The exact magnitude of listing gain or loss frequently differs from what GMP predicted. GMP is most unreliable for SME IPOs and during periods of rapid market movement. Use GMP as one input among several — not as a standalone prediction.
Introduction: The Question Every IPO Investor Asks
The GMP for an upcoming IPO is ₹80 on a ₹200 issue price — a 40% expected listing gain. Should you apply?
GMP is the most talked-about IPO signal in India. Every investor checks it. Financial news platforms update it hourly. But how often is it actually right?
This article examines the track record of GMP as a predictor, explains why it fails when it does, and tells you what to use alongside GMP for better decision-making.
The Honest Answer: Directionally Yes, Precisely No
Let’s be direct: GMP is right more often than it is wrong about direction, but the magnitude is often off.
Historical patterns from Indian IPO data spanning 2020–2025 reveal:
When GMP is positive and high (above 30%), the stock listed at a gain roughly 70–75% of the time. That sounds reliable — until you consider that 25–30% of high-GMP IPOs disappointed on listing day.
When GMP is negative, the stock listed below issue price roughly 65–70% of the time. Again, useful but not guaranteed.
The magnitude mismatch is consistent: A GMP of 50% rarely translates to a 50% listing gain. It might deliver 20%, or 60%, or sometimes a loss. The grey market gets the direction approximately right more often than a coin flip, but should never be treated as a precise price target.
Why GMP Fails: Structural Limitations
1. Volume Is Insignificant
The grey market handles a tiny fraction of total IPO demand. In a major IPO where lakhs of retail investors apply for millions of shares, the grey market might involve a few hundred trades among a few dozen dealers. This sample size cannot represent aggregate demand from across India.
2. No Verified Data
GMP figures you see on websites — including ours — come from dealer networks and market intelligence. No regulatory body records or audits grey market transactions. The numbers are estimates from a limited, informal network.
3. Manipulation Is Possible
For smaller IPOs (especially SME), promoters, operators, or large applicants can theoretically push GMP up to drive retail enthusiasm and subscription, then allow it to correct after subscription closes. This pattern has been observed in SME IPO markets.
4. GMP Ignores Macro Risk
The grey market prices IPO-specific sentiment. It does not account for what Nifty might do on listing day. If Nifty falls 2% the morning an IPO lists, even a high-GMP stock will open well below the implied listing price. Macro risk is entirely absent from GMP’s signal.
5. GMP Collapses Near Listing
In many IPOs, GMP starts high, attracts retail excitement, and then declines as listing day approaches — sometimes turning negative in the final 48 hours. Investors who checked GMP a week before listing and made decisions based on that number saw a very different reality on listing day.
Case Patterns Where GMP Was Right
High GMP, Strong Listing: The most common pattern in bull markets. IPOs with strong fundamentals, heavy QIB subscription, and sustained high GMP frequently deliver listing gains in line with or slightly below GMP expectations. In a rising Nifty environment (2021, 2023 rallies), many high-GMP IPOs listed at 20–40% gains when GMP had predicted 25–50%.
Negative GMP, Weak Listing: When GMP goes negative before listing — especially if it was positive earlier and then deteriorated — listing disappointment is more reliably predicted. Declining GMP is one of the more consistent signals available: it indicates that grey market participants who had taken positions are now exiting at a loss, suggesting broader sentiment deterioration.
Case Patterns Where GMP Failed
High GMP, Flat or Negative Listing: The most costly failure mode for retail investors. Several prominent cases from 2021–2024 saw IPOs with 40–60% GMP list flat or even below issue price when:
- Nifty fell sharply on listing morning
- Anchor investor lock-up expiry concerns emerged
- Post-subscription subscription data showed grey market positioning was unwinding
Low or Zero GMP, Strong Listing: Some IPOs with muted grey market activity — often because the IPO was in a niche sector with limited grey market participation — listed strongly when institutional demand on listing day exceeded expectations. These are harder to predict from GMP alone.
SME IPO GMP Manipulation: 2024 saw several high-profile cases of SME IPOs with GMP above 100% listing at flat or negative prices. SEBI subsequently increased scrutiny of SME IPO processes, noting that some GMP figures appeared disconnected from underlying fundamentals.
What to Use Alongside GMP
For a more complete picture before applying:
- QIB Subscription Level: High QIB oversubscription (10x or more) is one of the most reliable signals of listing strength. Institutional investors do significant due diligence — their participation carries more signal than grey market activity.
- Retail and NII Subscription Levels: Overall oversubscription reflects broad demand. But note that massive retail oversubscription (50x, 100x) can indicate speculative listing-gain hunting rather than genuine investment interest.
- Anchor Investor Quality: The names on the anchor investor list matter. Tier-1 domestic mutual funds (SBI MF, HDFC MF, Mirae) taking anchor allocation signals institutional conviction.
- Company Financials: Revenue growth, profit margins, debt levels, and P/E ratio compared to listed peers provide the fundamental anchor. A high-GMP IPO with weak fundamentals is a red flag regardless of grey market enthusiasm.
- GMP Trend: A rising GMP in the 3 days before listing is more bullish than a GMP that was once high and has been falling. Always look at the trend, not just the current number. Our IPO GMP Today page shows daily GMP movement for all active IPOs.
GMP Reliability by IPO Category
| IPO Category | GMP Directional Accuracy | Notes |
| Mainboard (strong fundamentals, high QIB) | 75–80% | Most reliable |
| Mainboard (weak fundamentals) | 55–65% | Lower reliability |
| SME IPO | 50–65% | Highly susceptible to manipulation |
| During bull market (Nifty uptrend) | Higher | Market tailwind helps all listings |
| During correction (Nifty downtrend) | Lower | Macro risk overrides GMP signal |
Frequently Asked Questions
Is GMP always accurate?
No. Directional accuracy is roughly 70–75% historically. The exact listing price regularly diverges from GMP predictions.
Should I apply for an IPO only based on GMP?
No. GMP should be one of several factors — combine it with QIB subscription levels, anchor investor quality, company fundamentals, and your own risk assessment.
Is a falling GMP a bad sign?
Yes, generally. A GMP that has declined significantly from its peak (especially turning negative) is a reliable warning that grey market sentiment has deteriorated. Treat declining GMP as a caution signal.
Is GMP more reliable for Mainboard or SME IPOs?
Mainboard IPOs with strong institutional participation have more reliable GMP signals. SME IPO GMP is significantly less reliable and more susceptible to manipulation.
Can GMP be negative after being positive?
Yes, and it happens frequently. GMP is dynamic — it shifts based on subscription progress, market conditions, and grey market positioning. Always check the latest GMP, not data from several days ago.
Summary
- GMP directional accuracy is roughly 70–75% — useful but not guaranteed
- Magnitude accuracy is consistently poor — do not treat GMP as a price target
- GMP fails most often when Nifty moves sharply, grey market is thin, or SME IPOs are involved
- Use GMP alongside QIB subscription, anchor investor quality, and fundamentals
- Declining GMP is a more reliable negative signal than high GMP is a positive one
